Prediction of renal and cardiometabolic outcomes in gout during urate-lowering therapy by sonography.

Sonographic MSU crystal burden was unhelpful in predicting renal and cardiometabolic events during the first year of ULT. Reaching the SU target prevented cardiometabolic events, while its benefit in preserving/improving renal function is unclear.